238 related articles for article (PubMed ID: 23650168)
1. Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo.
Spickler C; Lippens J; Laberge MK; Desmeules S; Bellavance É; Garneau M; Guo T; Hucke O; Leyssen P; Neyts J; Vaillancourt FH; Décor A; O'Meara J; Franti M; Gauthier A
Antimicrob Agents Chemother; 2013 Jul; 57(7):3358-68. PubMed ID: 23650168
[TBL] [Abstract][Full Text] [Related]
2. Coxsackievirus mutants that can bypass host factor PI4KIIIβ and the need for high levels of PI4P lipids for replication.
van der Schaar HM; van der Linden L; Lanke KH; Strating JR; Pürstinger G; de Vries E; de Haan CA; Neyts J; van Kuppeveld FJ
Cell Res; 2012 Nov; 22(11):1576-92. PubMed ID: 22945356
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity.
Arita M; Kojima H; Nagano T; Okabe T; Wakita T; Shimizu H
J Virol; 2011 Mar; 85(5):2364-72. PubMed ID: 21177810
[TBL] [Abstract][Full Text] [Related]
4. Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses.
Grazia Martina M; Vicenti I; Bauer L; Crespan E; Rango E; Boccuto A; Olivieri N; Incerti M; Zwaagstra M; Allodi M; Bertoni S; Dreassi E; Zazzi M; van Kuppeveld FJM; Maga G; Radi M
ChemMedChem; 2021 Dec; 16(23):3548-3552. PubMed ID: 34382337
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the Role of Protein Kinase D in Human Rhinovirus Replication.
Guedán A; Swieboda D; Charles M; Toussaint M; Johnston SL; Asfor A; Panjwani A; Tuthill TJ; Danahay H; Raynham T; Mousnier A; Solari R
J Virol; 2017 May; 91(9):. PubMed ID: 28228588
[TBL] [Abstract][Full Text] [Related]
6. New small-molecule inhibitors effectively blocking picornavirus replication.
Ford Siltz LA; Viktorova EG; Zhang B; Kouiavskaia D; Dragunsky E; Chumakov K; Isaacs L; Belov GA
J Virol; 2014 Oct; 88(19):11091-107. PubMed ID: 25008939
[TBL] [Abstract][Full Text] [Related]
7. PI4KIII inhibitor enviroxime impedes the replication of the hepatitis C virus by inhibiting PI3 kinases.
Delang L; Harak C; Benkheil M; Khan H; Leyssen P; Andrews M; Lohmann V; Neyts J
J Antimicrob Chemother; 2018 Dec; 73(12):3375-3384. PubMed ID: 30219827
[TBL] [Abstract][Full Text] [Related]
8. Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C.
Mello C; Aguayo E; Rodriguez M; Lee G; Jordan R; Cihlar T; Birkus G
Antimicrob Agents Chemother; 2014; 58(3):1546-55. PubMed ID: 24366736
[TBL] [Abstract][Full Text] [Related]
9. Oxysterol-binding protein family I is the target of minor enviroxime-like compounds.
Arita M; Kojima H; Nagano T; Okabe T; Wakita T; Shimizu H
J Virol; 2013 Apr; 87(8):4252-60. PubMed ID: 23365445
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel aminothiazoles as antiviral compounds acting against human rhinovirus.
Décor A; Grand-Maître C; Hucke O; O'Meara J; Kuhn C; Constantineau-Forget L; Brochu C; Malenfant E; Bertrand-Laperle M; Bordeleau J; Ghiro E; Pesant M; Fazal G; Gorys V; Little M; Boucher C; Bordeleau S; Turcotte P; Guo T; Garneau M; Spickler C; Gauthier A
Bioorg Med Chem Lett; 2013 Jul; 23(13):3841-7. PubMed ID: 23726345
[TBL] [Abstract][Full Text] [Related]
11. Development of a high-throughput human rhinovirus infectivity cell-based assay for identifying antiviral compounds.
Phillips T; Jenkinson L; McCrae C; Thong B; Unitt J
J Virol Methods; 2011 May; 173(2):182-8. PubMed ID: 21300110
[TBL] [Abstract][Full Text] [Related]
12. Mode of action of 2-furylmercury chloride, an anti-rhinovirus compound.
Verheyden B; Andries K; Rombaut B
Antiviral Res; 2004 Mar; 61(3):189-94. PubMed ID: 15168800
[TBL] [Abstract][Full Text] [Related]
13. Small interfering RNA molecules as potential anti-human rhinovirus agents: in vitro potency, specificity, and mechanism.
Phipps KM; Martinez A; Lu J; Heinz BA; Zhao G
Antiviral Res; 2004 Jan; 61(1):49-55. PubMed ID: 14670593
[TBL] [Abstract][Full Text] [Related]
14. The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus.
Heinz BA; Vance LM
J Virol; 1995 Jul; 69(7):4189-97. PubMed ID: 7769678
[TBL] [Abstract][Full Text] [Related]
15. Anti-hepatitis C virus activity and toxicity of type III phosphatidylinositol-4-kinase beta inhibitors.
Lamarche MJ; Borawski J; Bose A; Capacci-Daniel C; Colvin R; Dennehy M; Ding J; Dobler M; Drumm J; Gaither LA; Gao J; Jiang X; Lin K; McKeever U; Puyang X; Raman P; Thohan S; Tommasi R; Wagner K; Xiong X; Zabawa T; Zhu S; Wiedmann B
Antimicrob Agents Chemother; 2012 Oct; 56(10):5149-56. PubMed ID: 22825118
[TBL] [Abstract][Full Text] [Related]
16. Evidence that enviroxime targets multiple components of the rhinovirus 14 replication complex.
Brown-Augsburger P; Vance LM; Malcolm SK; Hsiung H; Smith DP; Heinz BA
Arch Virol; 1999; 144(8):1569-85. PubMed ID: 10486111
[TBL] [Abstract][Full Text] [Related]
17. Antiviral activity and possible mode of action of ellagic acid identified in Lagerstroemia speciosa leaves toward human rhinoviruses.
Park SW; Kwon MJ; Yoo JY; Choi HJ; Ahn YJ
BMC Complement Altern Med; 2014 May; 14():171. PubMed ID: 24885569
[TBL] [Abstract][Full Text] [Related]
18. The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery.
Rollinger JM; Schmidtke M
Med Res Rev; 2011 Jan; 31(1):42-92. PubMed ID: 19714577
[TBL] [Abstract][Full Text] [Related]
19. A novel, broad-spectrum inhibitor of enterovirus replication that targets host cell factor phosphatidylinositol 4-kinase IIIβ.
van der Schaar HM; Leyssen P; Thibaut HJ; de Palma A; van der Linden L; Lanke KH; Lacroix C; Verbeken E; Conrath K; Macleod AM; Mitchell DR; Palmer NJ; van de Poël H; Andrews M; Neyts J; van Kuppeveld FJ
Antimicrob Agents Chemother; 2013 Oct; 57(10):4971-81. PubMed ID: 23896472
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307.
De Palma AM; Thibaut HJ; van der Linden L; Lanke K; Heggermont W; Ireland S; Andrews R; Arimilli M; Al-Tel TH; De Clercq E; van Kuppeveld F; Neyts J
Antimicrob Agents Chemother; 2009 May; 53(5):1850-7. PubMed ID: 19237651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
